Skip to main content
. 2021 Mar 17;12:646095. doi: 10.3389/fimmu.2021.646095

Figure 2.

Figure 2

Laboratory data for SARS-CoV-2 positive patients (n=55) according to their treatment regimen and at different admission timepoints (median, IQR): (A) Interleukin-6; (B) C-Reactive protein; (C) Lymphocytes; (D) Lactate dehydrogenase (LDH); (E) Ferritin level and (F) D-dimer.